GlassScriptPhysician profile
Michael Dinh Le
NPI 1437591500
$1,981.75
in general payments reported to CMS, 2019-2025
9 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $794 · 2020: $202 · 2021: $222 · 2022: $135 · 2023: $452 · 2024: $76.69 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $345 · Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $345.00 |
| Food and Beverage | $283.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,363.31 | 2019-2025 | Acuvue |
| Coopervision INC. | $309.40 | 2019-2025 | Paragon Crt, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $140.38 | 2019 | |
| Alcon Vision LLC | $62.15 | 2019 | |
| Sight Sciences, INC. | $24.18 | 2023 | Tearcare System |
| Abb Con-Cise Optical Group LLC | $23.19 | 2020 | |
| Abbvie INC. | $22.50 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.